Refractory GERD: What s a Gastroenterologist To Do?

Similar documents
ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease

GERD DIAGNOSIS & TREATMENT DISCLOSURES 4/18/2018

Refractory GERD : case presentation and discussion

Refractory GERD. Kenneth R. DeVault, MD, FACG President American College of Gastroenterology Chair Department of Medicine Mayo Clinic Florida

Gastroesophageal reflux disease (GERD) is a common chronic

Hold the Wrap! There is so much more to be done!

GERD: 2014 Dilemmas and Solutions. Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University

Unmet Needs in the Management of Gastroesophageal Reflux Disease

GERD: Pitfalls and Pearls

Four-Day Bravo ph Capsule Monitoring With and Without Proton Pump Inhibitor Therapy

Burning Issues in Gastroesophageal Reflux Disease (GERD)

NEGATIVE ENDOSCOPY, What is the Diagnosis and Treatment?

Original Policy Date 12:2013

Disclosures. Proton Pump Inhibitors Deprescribing? Deprescribing PPI Objectives. Deprescribing. Proton Pump Inhibitors (PPI) 5/28/2018.

Policy #: 138 Latest Review Date: November 2016

Disclosures. Heartburn and Barrett s Esophagus. Heartburn and Barrett s Esophagus. GERD is common in the U.S. None

Eosinophilic Esophagitis: Extraesophageal Manifestations

Esophageal ph Monitoring

GERD: How to. Failures

GERD is a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications

Clinical Policy Title: Esophageal ph monitoring

Maximizing Outcome of Extraesophageal Reflux Disease. (GERD) is often accompanied

Gastroesophageal Reflux Disease in Infants and Children

Corporate Medical Policy

In the Name of God. Refractory GERD

GERD: A linical Clinical Clinical Update Objectives

Findings of impedance ph-monitoring in patients with atypical gastroesophageal reflux symptoms

Dysphagia. Conflicts of Interest

Extraesophageal GERD: Fact or Fiction?

Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and ph

Gastroesophageal Reflux Disease, Paraesophageal Hernias &

Prevalence and Clinical Characteristics of Refractoriness to Optimal Proton Pump Inhibitor Therapy in Non-erosive Reflux Disease

Achalasia is a rare disease with an annual incidence estimated REVIEWS. Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia

Related Policies None

Review article: the measurement of non-acid gastro-oesophageal reflux

Gastro esophageal reflux disease DR. AMMAR I. ABDUL-LATIF

A stepwise protocol for the treatment of refractory gastroesophageal reflux-induced chronic cough

Medical Policy An independent licensee of the Blue Cross Blue Shield Association.

Patients with refractory gastroesophageal reflux disease: diagnostic tools

CMEARTICLE. WHAT CAN I DO IN MY PRACTICE? History. Daphne Ang 1, MBBS, FRCP (Edin), Choon How How 2, MMed, FCFP, Tiing Leong Ang 1, MBBS, FRCP (Edin)

Understanding GERD. & Stretta Therapy. GERD (gĕrd): Gastroesophageal Reflux Disease

Speaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015

Functional Heartburn and Dyspepsia

Medical Policy An independent licensee of the Blue Cross Blue Shield Association.

The Frequency of Gastroesophageal Reflux Disease in Nutcracker Esophagus and the Effect of Acid-Reduction Therapy on the Motor Abnormality

What s New in the Management of Esophageal Disease

GASTROESOPHAGEAL REFLUX

Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux

Gastroesophageal reflux disease (GERD) is a common ALIMENTARY TRACT

Symptom Characteristics and Psychosomatic Profiles in Different Spectrum of Gastroesophageal Reflux Disease

What can you expect from the lab?

Gastroesophageal Reflux Disease (GERD)

Page 1. Objectives. The Role of the Pharmacist as Gatekeeper to the Appropriate Use of OTC PPI Therapy in Frequent Heartburn

Medical Policy An independent licensee of the Blue Cross Blue Shield Association.

Definition of GERD American College of Gastroenterology

JNM Journal of Neurogastroenterology and Motility

OTC PPI Therapy in Frequent Heartburn

Optimal Management of GERD with Dexlansoprazole - Extended plasma concentration and dosing flexibility with a dual delayed release PPI

Index. Note: Page numbers of article titles are in boldface type.

Functional Dyspepsia

Gastroesophageal Reflux Disease (GERD)

Alimentary Pharmacology & Therapeutics SUMMARY

ACID REFLUX & GERD: The Unsettling Reality in Canada

Acidic and Non-Acidic Reflux During Sleep Under Conditions of Powerful Acid Suppression*

QUICK QUERIES. Topical Questions, Sound Answers

MEDICAL NECESSITY GUIDELINE

Review article: gastric acidity ) comparison of esomeprazole with other proton pump inhibitors

PeriOperative Concerns for Anti Reflux Procedure Patients

A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?

Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies

Endoscopic vs Surgical Therapies for GERD: Is it Time to Put down the Scalpel?

Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily a randomized, two-way crossover study

Esophageal Eosinophilia and Eosinophilic Esophagitis. Bible Class 09. Mai 2018

Putting Chronic Heartburn On Ice

Obesity Is Associated With Increased Transient Lower Esophageal Sphincter Relaxation. Introduction. Predisposing factor. Introduction.

GERD: Diagnosing and treating the burn

WHAT IS GASTROESOPHAGEAL REFLUX DISEASE (GERD)?

Characteristics of gastroesophageal reflux in patients with and without excessive gastroesophageal acid exposure

Successful resolution of refractory chronic cough induced by gastroesophageal reflux with treatment of baclofen

Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy

127 Chapter 1 Chapter 2 Chapter 3

A Prospective, Randomized, Placebo-controlled, Double-Blind Study of Rabeprazole for Therapeutic Trial in Chronic Idiopathic Laryngitis ABSTRACT

AGA SECTION. Gastroenterology 2016;150:

Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease where next?

Simultaneous Intraesophageal Impedance and ph Measurement of Acid and Nonacid Gastroesophageal Reflux: Effect of Omeprazole

ENDOLUMINAL THERAPIES FOR GERD. University of Colorado Department of Surgery Grand Rounds March 31st, 2008

TBURN TBURN BURN ARTBURN EARTBURN EART HEARTBURN: HOW TO GET IT OFF YOUR CHEST

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

Options for Gastroesophageal Reflux: Endoluminal. W. Scott Melvin, M.D. Montefiore Medical System and the Albert Einstein School of Medicine

Validation of a Four-Graded Scale for Severity of Heartburn in Patients with Symptoms of Gastroesophageal Reflux Disease

Laryngopharyngeal Reflux

Approach to Patients with Non-Cardiac Chest Pain

Proton Pump Inhibitors (PPIs) (Sherwood Employer Group)

La tasca acida nella MRGE: aspetti patogenetici e terapeutici

Motility - Difficult Issues in Practice and How to Investigate

Nexium 24HR Pharmacy Training

Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastroesophageal reflux disease

Extraesophageal presentations of gastroesophageal reflux disease: the case for aggressive diagnosis and treatment

Gastroesophageal Reflux Evaluation in Patients Affected by Chronic Cough: Restech Versus Multichannel Intraluminal Impedance/pH Metry

Treatment of Nonerosive Reflux Disease (Beyond Proton Pump Inhibitors)

Transcription:

Refractory GERD: What s a Gastroenterologist To Do? Philip O. Katz, MD, FACG Chairman, Division of Gastroenterology Einstein Medical Center Clinical Professor of Medicine Jefferson Medical College Philadelphia, PA

The Easy Patient Heartburn, typical Regurgitation Sleep disturbed On PPI twice a day, heartburn 85% better, still with regurgitation post prandial Never had a test

The Real Hard Patient Chronic Cough (5 years) Non smoker Normal Chest xray/ct Voice disturbance ENT says LPR, pulmonary says no asthma Dexlansoprazole once a day/h2 at bedtime no perceived improvement

What Do We Need to Know Does the patient REALLY have GERD If so how do we prove it. What is a reasonable approach? If truly refractory what are the options? If not GERD what to do (if you keep the patient)

Potential Causes of Continued Symptoms on PPI The patient has GERD but: Acid is not controlled Healing/symptom relief not complete despite good antisecretory therapy The patient has weakly acidic or non-acid reflux Hatlebakk JG, et al. Gastroenterol Clin North Am 1999;28:847-60.

Potential Causes for Continued Symptoms on PPI The patient does not have GERD (medication, eosinophilic esophagitis, functional heartburn) The response to PPI is impacted by concurrent functional medical illness (IBS, migraine, anxiety, chest pain) Some people really have more than one problem

Patients Still Do Not Optimize PPI 3.7 Therapy 27.8 29.6 38.9 > 60 minutes before meals As needed After meals At bedtime Gunaratnam NT, et al. Aliment Pharmacol Ther 2006;23:1473.

Options for the Work Up Perform EGD Ambulatory monitoring ph Impedance Esophageal function testing (manometry, impedance) Kahrilas P, et al. Gastroenterology 2008; 135:1392-1413. DeVault KR, et al. Am J Gastroenterol 2005 Jan;100(1):190-200.

Prolonged ph (Reflux) Monitoring Allows clinician to determine: The amount and timing of acid reflux The association between acid reflux and symptoms (does reflux precede symptom?) The effect of therapy on acid reflux Non-acid reflux (impedance) Reflux Height DeVault K, et al. Am J Gastroenterol 2005;100(1):190-200. Hirano I, Richter JE. Am J Gastroentrol 2007;102:668-85.

Should ph (Reflux) Monitoring Be Performed Off or On Therapy Low pre test probability of GERD at baseline/no diagnostic tests done OFF Medication (7-10 days) GERD likely OR known. EGD done ON Medication (impedance/ph) Kahrilas P, et al. Gastroenterology 2008; 135:1392-1413. Hirano I, Richter JE. Am J Gastroentrol 2007;102:668-85.

Patients with positive symptom index (%) 100% 90% 80% 70% Non Acid Reflux and Positive 72% Symptom Index 60% 50% 40% 30% 20% 10% 35% 32% 16% 14% 10% 22% 0% Regurgitation 18 Heartburn 20 Cough 22 Chest pain 25 Abdominal Sx 7 ENT symptoms 21 Others 37 Katz P, personal data from approx 1500 patients

Non Acid Reflux Options Baclofen Imipramine (functional) Surgery

No. Reflux Episodes Number of Reflux Episodes: Effect of Baclofen 250 200 206 Acid Nonacid Rereflux 150 100 89 73 50 0 32 19 3 Placebo Baclofen Vela MF, et al. Aliment Pharmacol Ther 2003; 17:243-251

No. symptom events Effect Of Baclofen On Number Of 120 100 80 97 Symptom Events 70 Placebo Baclofen 60 40 20 0 21 * 15 20 * 5 * 7 1 Total Acid-related Nonacidrelated * Noncorrelated * p<0.05 (Vela et al. Al Pharm Ther 2003)

Symptom improvement and resolution after LARS among those presenting with the symptom 100 80 23 22 60 40 18 29 22 Improved % Resolution % 20 0 67 70 57 47 40 Heartburn Regurgitation Dysphagia Cough Hoarseness Oelschlager BK, et al. Am J Gastroenterol 2008; 103:280-287.

Reflux on PPI with Positive Symptom Index: Surgery Outcome 19 Patients Heartburn-2 Regurgitation-3 NAR Acid Symptoms not associated with reflux Cough-7 Throat Clearing-1 Hoarseness-1 Heartburn-3 Nausea-1 Heartburn-1

Esophageal Manometry Recommended by AGA technical review if GERD not present by above testing Especially helpful with dysphagia Rarely will find Achalasia/Spasm Upper sphincter abnormalities seen in >50% of ENT referrals. Significance unknown AGA Technical Review. Gastroenterology 2008

Ambulatory reflux testing OFF PPI Primary outcome is focused on acid reflux Prolonged wireless ph monitoring (48 hours) Or 24 hour catheter (ph alone or ph impedance)

Normal esophageal acid exposure Negative symptom-reflux association Likelihood of GERD: Low Typical Extraesophageal Diagnosis c/w Functional Heartburn/ Chest Pain Look for alternate diagnosis

Pathological esophageal acid exposure Positive symptom-reflux association Likelihood of GERD: High Treatment optimization - Escalation of acid suppression - Document compliance No response

Ambulatory reflux testing ON PPI (Can be first test in several circumstances) 24 hour phimpedance Persistent Acid Non-acid Hypersensitive Not associated with GERD Escalation of reflux therapy is reasonable Escalation of reflux therapy may be based on symptoms/mechanism Look for alternate diagnosis

Referral for Antireflux Procedure Without a previous confirmed diagnosis of Pathologic acid gastroesophageal reflux Ambulatory reflux testing OFF PPI primary outcome is focused on acid reflux Prolonged wireless ph monitoring (48 hours) or 24 hour catheter (ph alone/or ph-impedance) Normal esophageal acid exposure Negative symptom-reflux association Pathological esophageal acid exposure Positive symptom-reflux association Likelihood of GERD: Low Likelihood of GERD: High Response to antireflux procedure is poor PPI responder or intolerant to PPI Response to antireflux procedure is good No response to PPI Consider further testing ON therapy if a functional /alternative diagnosis is possible